Discover the best database migration solutions for 2026. Compare cloud, custom, and fast options with real cost calculations ...

Importing MySQL databases into FileMaker Pro offers a quick-start to the development of new workgroup solutions.

Microsoft reported on cloud, AI and security growth on its Q2 earnings report, setting itself and the channel up for ...

Devart, a leading developer of database management software, is offering dbForge 2025.3, the latest update to its unified ecosystem of professional database tools-delivering expanded connectivity, ...

Cameron Troilo Properties is the first business to obtain a liquor license in Lower Makefield after a referendum last year overturned the law governing the serving of alcohol in a historically dry ...

Update, Jan 13th, 2026: Multiple Target employees have now confirmed in our follow-up report the authenticity of leaked source code sample set and shared internal announcements regarding an access ...

Key benefits of Windows Server IoT for edge and industrial applications; how virtualization reduces hardware footprint and simplifies workload management; edition and licensing options tailored for ...

Here's a look at the most recent Patch Tuesday release from Microsoft as well as a collection of recent updates so you can track what's changed. Long before Taco Tuesday became part of the pop-culture ...

Learn everything you need to know about two of the leading cloud-based infrastructure as a service providers, including how ...

Shanghai-based Harbour BioMed’s acquisition of a stake in US-based Spruce Biosciences is the latest example of China’s novel drug developers progressing from one-time licensing deals into long-lasting ...

WSUS is deprecated, leaving IT teams with an outdated, high-maintenance tool lacking third-party support and remote capabilities. This guide explains WSUS limitations, compares it to modern patching, ...

Artificial-intelligence-powered drug developer Insilico Medicine is set for a $10 million upfront payment from a fresh-faced Chinese biotech for half of the rights to a brain-penetrant NLRP3 inhibitor ...